nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—Pharyngitis—Ezetimibe—atherosclerosis	0.00173	0.0024	CcSEcCtD
Tizanidine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00171	0.00238	CcSEcCtD
Tizanidine—Weight decreased—Pravastatin—atherosclerosis	0.0017	0.00236	CcSEcCtD
Tizanidine—Erythema multiforme—Lovastatin—atherosclerosis	0.00168	0.00233	CcSEcCtD
Tizanidine—Depression—Pravastatin—atherosclerosis	0.00167	0.00232	CcSEcCtD
Tizanidine—Hepatitis—Simvastatin—atherosclerosis	0.00166	0.00231	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00166	0.0023	CcSEcCtD
Tizanidine—Jaundice—Niacin—atherosclerosis	0.00166	0.0023	CcSEcCtD
Tizanidine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00165	0.00229	CcSEcCtD
Tizanidine—Erythema multiforme—Ezetimibe—atherosclerosis	0.00165	0.00229	CcSEcCtD
Tizanidine—Myocardial infarction—Pravastatin—atherosclerosis	0.00164	0.00228	CcSEcCtD
Tizanidine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00164	0.00228	CcSEcCtD
Tizanidine—Jaundice—Pravastatin—atherosclerosis	0.00163	0.00226	CcSEcCtD
Tizanidine—Sweating—Niacin—atherosclerosis	0.00163	0.00226	CcSEcCtD
Tizanidine—Angiopathy—Ezetimibe—atherosclerosis	0.00158	0.00219	CcSEcCtD
Tizanidine—Immune system disorder—Ezetimibe—atherosclerosis	0.00158	0.00218	CcSEcCtD
Tizanidine—Erythema multiforme—Simvastatin—atherosclerosis	0.00157	0.00218	CcSEcCtD
Tizanidine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00157	0.00218	CcSEcCtD
Tizanidine—Sinusitis—Pravastatin—atherosclerosis	0.00157	0.00218	CcSEcCtD
Tizanidine—Alopecia—Lovastatin—atherosclerosis	0.00157	0.00218	CcSEcCtD
Tizanidine—Arthralgia—Rosuvastatin—atherosclerosis	0.00156	0.00216	CcSEcCtD
Tizanidine—Alopecia—Ezetimibe—atherosclerosis	0.00154	0.00214	CcSEcCtD
Tizanidine—Haemoglobin—Niacin—atherosclerosis	0.00154	0.00213	CcSEcCtD
Tizanidine—Rhinitis—Niacin—atherosclerosis	0.00153	0.00212	CcSEcCtD
Tizanidine—Mental disorder—Ezetimibe—atherosclerosis	0.00153	0.00212	CcSEcCtD
Tizanidine—Haemorrhage—Niacin—atherosclerosis	0.00153	0.00212	CcSEcCtD
Tizanidine—Hepatitis—Niacin—atherosclerosis	0.00153	0.00212	CcSEcCtD
Tizanidine—Flatulence—Lovastatin—atherosclerosis	0.00153	0.00212	CcSEcCtD
Tizanidine—Rhinitis—Pravastatin—atherosclerosis	0.00151	0.00209	CcSEcCtD
Tizanidine—Hepatitis—Pravastatin—atherosclerosis	0.0015	0.00209	CcSEcCtD
Tizanidine—Confusional state—Rosuvastatin—atherosclerosis	0.0015	0.00208	CcSEcCtD
Tizanidine—Back pain—Lovastatin—atherosclerosis	0.0015	0.00208	CcSEcCtD
Tizanidine—Flatulence—Ezetimibe—atherosclerosis	0.0015	0.00207	CcSEcCtD
Tizanidine—Pharyngitis—Pravastatin—atherosclerosis	0.00149	0.00207	CcSEcCtD
Tizanidine—Muscle spasms—Lovastatin—atherosclerosis	0.00149	0.00206	CcSEcCtD
Tizanidine—Infection—Rosuvastatin—atherosclerosis	0.00148	0.00205	CcSEcCtD
Tizanidine—Alopecia—Simvastatin—atherosclerosis	0.00147	0.00204	CcSEcCtD
Tizanidine—Back pain—Ezetimibe—atherosclerosis	0.00147	0.00204	CcSEcCtD
Tizanidine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00146	0.00203	CcSEcCtD
Tizanidine—Muscle spasms—Ezetimibe—atherosclerosis	0.00146	0.00202	CcSEcCtD
Tizanidine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00146	0.00202	CcSEcCtD
Tizanidine—Vision blurred—Lovastatin—atherosclerosis	0.00146	0.00202	CcSEcCtD
Tizanidine—Mental disorder—Simvastatin—atherosclerosis	0.00146	0.00202	CcSEcCtD
Tizanidine—Tremor—Lovastatin—atherosclerosis	0.00145	0.00201	CcSEcCtD
Tizanidine—Ill-defined disorder—Lovastatin—atherosclerosis	0.00144	0.00199	CcSEcCtD
Tizanidine—Flatulence—Simvastatin—atherosclerosis	0.00143	0.00198	CcSEcCtD
Tizanidine—Tinnitus—Niacin—atherosclerosis	0.00142	0.00197	CcSEcCtD
Tizanidine—Erythema multiforme—Pravastatin—atherosclerosis	0.00142	0.00197	CcSEcCtD
Tizanidine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00141	0.00195	CcSEcCtD
Tizanidine—Anaemia—Ezetimibe—atherosclerosis	0.0014	0.00195	CcSEcCtD
Tizanidine—Tinnitus—Pravastatin—atherosclerosis	0.0014	0.00194	CcSEcCtD
Tizanidine—Malaise—Lovastatin—atherosclerosis	0.0014	0.00194	CcSEcCtD
Tizanidine—Cardiac disorder—Pravastatin—atherosclerosis	0.0014	0.00194	CcSEcCtD
Tizanidine—Muscle spasms—Simvastatin—atherosclerosis	0.00139	0.00193	CcSEcCtD
Tizanidine—Vertigo—Lovastatin—atherosclerosis	0.00139	0.00193	CcSEcCtD
Tizanidine—Angiopathy—Niacin—atherosclerosis	0.00139	0.00192	CcSEcCtD
Tizanidine—Leukopenia—Lovastatin—atherosclerosis	0.00139	0.00192	CcSEcCtD
Tizanidine—Malaise—Ezetimibe—atherosclerosis	0.00137	0.0019	CcSEcCtD
Tizanidine—Vision blurred—Simvastatin—atherosclerosis	0.00136	0.00189	CcSEcCtD
Tizanidine—Arrhythmia—Niacin—atherosclerosis	0.00136	0.00189	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00136	0.00188	CcSEcCtD
Tizanidine—Tremor—Simvastatin—atherosclerosis	0.00136	0.00188	CcSEcCtD
Tizanidine—Alopecia—Niacin—atherosclerosis	0.00135	0.00187	CcSEcCtD
Tizanidine—Ill-defined disorder—Simvastatin—atherosclerosis	0.00134	0.00186	CcSEcCtD
Tizanidine—Arrhythmia—Pravastatin—atherosclerosis	0.00134	0.00186	CcSEcCtD
Tizanidine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00134	0.00186	CcSEcCtD
Tizanidine—Anaemia—Simvastatin—atherosclerosis	0.00134	0.00186	CcSEcCtD
Tizanidine—Alopecia—Pravastatin—atherosclerosis	0.00133	0.00184	CcSEcCtD
Tizanidine—Arthralgia—Lovastatin—atherosclerosis	0.00132	0.00183	CcSEcCtD
Tizanidine—Anxiety—Lovastatin—atherosclerosis	0.00131	0.00182	CcSEcCtD
Tizanidine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00131	0.00182	CcSEcCtD
Tizanidine—Hypertension—Ezetimibe—atherosclerosis	0.00131	0.00182	CcSEcCtD
Tizanidine—Flatulence—Niacin—atherosclerosis	0.00131	0.00182	CcSEcCtD
Tizanidine—Malaise—Simvastatin—atherosclerosis	0.00131	0.00181	CcSEcCtD
Tizanidine—Tension—Niacin—atherosclerosis	0.0013	0.00181	CcSEcCtD
Tizanidine—Discomfort—Lovastatin—atherosclerosis	0.0013	0.00181	CcSEcCtD
Tizanidine—Vertigo—Simvastatin—atherosclerosis	0.0013	0.0018	CcSEcCtD
Tizanidine—Leukopenia—Simvastatin—atherosclerosis	0.0013	0.0018	CcSEcCtD
Tizanidine—Arthralgia—Ezetimibe—atherosclerosis	0.00129	0.00179	CcSEcCtD
Tizanidine—Nervousness—Niacin—atherosclerosis	0.00129	0.00179	CcSEcCtD
Tizanidine—Flatulence—Pravastatin—atherosclerosis	0.00129	0.00179	CcSEcCtD
Tizanidine—Dry mouth—Lovastatin—atherosclerosis	0.00129	0.00179	CcSEcCtD
Tizanidine—Tension—Pravastatin—atherosclerosis	0.00128	0.00178	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00128	0.00178	CcSEcCtD
Tizanidine—Muscle spasms—Niacin—atherosclerosis	0.00128	0.00177	CcSEcCtD
Tizanidine—Discomfort—Ezetimibe—atherosclerosis	0.00128	0.00177	CcSEcCtD
Tizanidine—Constipation—Rosuvastatin—atherosclerosis	0.00127	0.00177	CcSEcCtD
Tizanidine—Confusional state—Lovastatin—atherosclerosis	0.00127	0.00177	CcSEcCtD
Tizanidine—Nervousness—Pravastatin—atherosclerosis	0.00127	0.00176	CcSEcCtD
Tizanidine—Dry mouth—Ezetimibe—atherosclerosis	0.00126	0.00175	CcSEcCtD
Tizanidine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00126	0.00175	CcSEcCtD
Tizanidine—Muscle spasms—Pravastatin—atherosclerosis	0.00126	0.00175	CcSEcCtD
Tizanidine—Infection—Lovastatin—atherosclerosis	0.00126	0.00174	CcSEcCtD
Tizanidine—Vision blurred—Niacin—atherosclerosis	0.00125	0.00174	CcSEcCtD
Tizanidine—Confusional state—Ezetimibe—atherosclerosis	0.00125	0.00173	CcSEcCtD
Tizanidine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00124	0.00172	CcSEcCtD
Tizanidine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00124	0.00172	CcSEcCtD
Tizanidine—Vision blurred—Pravastatin—atherosclerosis	0.00123	0.00171	CcSEcCtD
Tizanidine—Arthralgia—Simvastatin—atherosclerosis	0.00123	0.00171	CcSEcCtD
Tizanidine—Infection—Ezetimibe—atherosclerosis	0.00123	0.00171	CcSEcCtD
Tizanidine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00123	0.0017	CcSEcCtD
Tizanidine—Anxiety—Simvastatin—atherosclerosis	0.00123	0.0017	CcSEcCtD
Tizanidine—Tremor—Pravastatin—atherosclerosis	0.00123	0.0017	CcSEcCtD
Tizanidine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00122	0.00169	CcSEcCtD
Tizanidine—Discomfort—Simvastatin—atherosclerosis	0.00122	0.00169	CcSEcCtD
Tizanidine—Nervous system disorder—Ezetimibe—atherosclerosis	0.00122	0.00169	CcSEcCtD
Tizanidine—Ill-defined disorder—Pravastatin—atherosclerosis	0.00121	0.00168	CcSEcCtD
Tizanidine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00121	0.00168	CcSEcCtD
Tizanidine—Anaemia—Pravastatin—atherosclerosis	0.00121	0.00168	CcSEcCtD
Tizanidine—Skin disorder—Ezetimibe—atherosclerosis	0.0012	0.00167	CcSEcCtD
Tizanidine—Vertigo—Niacin—atherosclerosis	0.00119	0.00166	CcSEcCtD
Tizanidine—Syncope—Niacin—atherosclerosis	0.00119	0.00165	CcSEcCtD
Tizanidine—Confusional state—Simvastatin—atherosclerosis	0.00119	0.00165	CcSEcCtD
Tizanidine—Leukopenia—Niacin—atherosclerosis	0.00119	0.00165	CcSEcCtD
Tizanidine—Urticaria—Rosuvastatin—atherosclerosis	0.00118	0.00164	CcSEcCtD
Tizanidine—Oedema—Simvastatin—atherosclerosis	0.00118	0.00164	CcSEcCtD
Tizanidine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00118	0.00164	CcSEcCtD
Tizanidine—Malaise—Pravastatin—atherosclerosis	0.00118	0.00164	CcSEcCtD
Tizanidine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00118	0.00163	CcSEcCtD
Tizanidine—Vertigo—Pravastatin—atherosclerosis	0.00118	0.00163	CcSEcCtD
Tizanidine—Infection—Simvastatin—atherosclerosis	0.00117	0.00163	CcSEcCtD
Tizanidine—Leukopenia—Pravastatin—atherosclerosis	0.00117	0.00163	CcSEcCtD
Tizanidine—Loss of consciousness—Niacin—atherosclerosis	0.00117	0.00162	CcSEcCtD
Tizanidine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00116	0.0016	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00115	0.0016	CcSEcCtD
Tizanidine—Paraesthesia—Lovastatin—atherosclerosis	0.00113	0.00157	CcSEcCtD
Tizanidine—Arthralgia—Niacin—atherosclerosis	0.00113	0.00157	CcSEcCtD
Tizanidine—Hypertension—Pravastatin—atherosclerosis	0.00113	0.00157	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00113	0.00157	CcSEcCtD
Tizanidine—Dyspnoea—Lovastatin—atherosclerosis	0.00113	0.00156	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00112	0.00156	CcSEcCtD
Tizanidine—Arthralgia—Pravastatin—atherosclerosis	0.00111	0.00155	CcSEcCtD
Tizanidine—Paraesthesia—Ezetimibe—atherosclerosis	0.00111	0.00154	CcSEcCtD
Tizanidine—Dyspepsia—Lovastatin—atherosclerosis	0.00111	0.00154	CcSEcCtD
Tizanidine—Anxiety—Pravastatin—atherosclerosis	0.00111	0.00154	CcSEcCtD
Tizanidine—Dry mouth—Niacin—atherosclerosis	0.00111	0.00154	CcSEcCtD
Tizanidine—Dyspnoea—Ezetimibe—atherosclerosis	0.0011	0.00153	CcSEcCtD
Tizanidine—Discomfort—Pravastatin—atherosclerosis	0.0011	0.00153	CcSEcCtD
Tizanidine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.0011	0.00152	CcSEcCtD
Tizanidine—Dyspepsia—Ezetimibe—atherosclerosis	0.00109	0.00151	CcSEcCtD
Tizanidine—Fatigue—Lovastatin—atherosclerosis	0.00109	0.00151	CcSEcCtD
Tizanidine—Oedema—Niacin—atherosclerosis	0.00109	0.0015	CcSEcCtD
Tizanidine—Anaphylactic shock—Niacin—atherosclerosis	0.00109	0.0015	CcSEcCtD
Tizanidine—Constipation—Lovastatin—atherosclerosis	0.00108	0.0015	CcSEcCtD
Tizanidine—Confusional state—Pravastatin—atherosclerosis	0.00108	0.00149	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00108	0.00149	CcSEcCtD
Tizanidine—Asthenia—Rosuvastatin—atherosclerosis	0.00107	0.00148	CcSEcCtD
Tizanidine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00107	0.00148	CcSEcCtD
Tizanidine—Oedema—Pravastatin—atherosclerosis	0.00107	0.00148	CcSEcCtD
Tizanidine—Fatigue—Ezetimibe—atherosclerosis	0.00107	0.00148	CcSEcCtD
Tizanidine—Shock—Niacin—atherosclerosis	0.00107	0.00148	CcSEcCtD
Tizanidine—Infection—Pravastatin—atherosclerosis	0.00106	0.00147	CcSEcCtD
Tizanidine—Paraesthesia—Simvastatin—atherosclerosis	0.00106	0.00147	CcSEcCtD
Tizanidine—Constipation—Ezetimibe—atherosclerosis	0.00106	0.00147	CcSEcCtD
Tizanidine—Tachycardia—Niacin—atherosclerosis	0.00106	0.00147	CcSEcCtD
Tizanidine—Pruritus—Rosuvastatin—atherosclerosis	0.00105	0.00146	CcSEcCtD
Tizanidine—Skin disorder—Niacin—atherosclerosis	0.00105	0.00146	CcSEcCtD
Tizanidine—Dyspnoea—Simvastatin—atherosclerosis	0.00105	0.00146	CcSEcCtD
Tizanidine—Hyperhidrosis—Niacin—atherosclerosis	0.00105	0.00145	CcSEcCtD
Tizanidine—Thrombocytopenia—Pravastatin—atherosclerosis	0.00105	0.00145	CcSEcCtD
Tizanidine—Feeling abnormal—Lovastatin—atherosclerosis	0.00104	0.00144	CcSEcCtD
Tizanidine—Dyspepsia—Simvastatin—atherosclerosis	0.00104	0.00144	CcSEcCtD
Tizanidine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00103	0.00143	CcSEcCtD
Tizanidine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00103	0.00143	CcSEcCtD
Tizanidine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00102	0.00142	CcSEcCtD
Tizanidine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00102	0.00141	CcSEcCtD
Tizanidine—Fatigue—Simvastatin—atherosclerosis	0.00102	0.00141	CcSEcCtD
Tizanidine—Hypotension—Niacin—atherosclerosis	0.00101	0.00141	CcSEcCtD
Tizanidine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00101	0.00141	CcSEcCtD
Tizanidine—Constipation—Simvastatin—atherosclerosis	0.00101	0.0014	CcSEcCtD
Tizanidine—Urticaria—Lovastatin—atherosclerosis	0.001	0.00139	CcSEcCtD
Tizanidine—Abdominal pain—Lovastatin—atherosclerosis	0.000999	0.00139	CcSEcCtD
Tizanidine—Body temperature increased—Lovastatin—atherosclerosis	0.000999	0.00139	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000989	0.00137	CcSEcCtD
Tizanidine—Dizziness—Rosuvastatin—atherosclerosis	0.000986	0.00137	CcSEcCtD
Tizanidine—Urticaria—Ezetimibe—atherosclerosis	0.000984	0.00137	CcSEcCtD
Tizanidine—Body temperature increased—Ezetimibe—atherosclerosis	0.00098	0.00136	CcSEcCtD
Tizanidine—Abdominal pain—Ezetimibe—atherosclerosis	0.00098	0.00136	CcSEcCtD
Tizanidine—Paraesthesia—Niacin—atherosclerosis	0.000974	0.00135	CcSEcCtD
Tizanidine—Feeling abnormal—Simvastatin—atherosclerosis	0.000974	0.00135	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000973	0.00135	CcSEcCtD
Tizanidine—Dyspnoea—Niacin—atherosclerosis	0.000967	0.00134	CcSEcCtD
Tizanidine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000966	0.00134	CcSEcCtD
Tizanidine—Somnolence—Niacin—atherosclerosis	0.000965	0.00134	CcSEcCtD
Tizanidine—Paraesthesia—Pravastatin—atherosclerosis	0.000959	0.00133	CcSEcCtD
Tizanidine—Dyspepsia—Niacin—atherosclerosis	0.000955	0.00132	CcSEcCtD
Tizanidine—Dyspnoea—Pravastatin—atherosclerosis	0.000953	0.00132	CcSEcCtD
Tizanidine—Dyspepsia—Pravastatin—atherosclerosis	0.000941	0.0013	CcSEcCtD
Tizanidine—Rash—Rosuvastatin—atherosclerosis	0.00094	0.0013	CcSEcCtD
Tizanidine—Dermatitis—Rosuvastatin—atherosclerosis	0.000939	0.0013	CcSEcCtD
Tizanidine—Urticaria—Simvastatin—atherosclerosis	0.000939	0.0013	CcSEcCtD
Tizanidine—Abdominal pain—Simvastatin—atherosclerosis	0.000934	0.0013	CcSEcCtD
Tizanidine—Body temperature increased—Simvastatin—atherosclerosis	0.000934	0.0013	CcSEcCtD
Tizanidine—Hypersensitivity—Lovastatin—atherosclerosis	0.000931	0.00129	CcSEcCtD
Tizanidine—Fatigue—Pravastatin—atherosclerosis	0.000921	0.00128	CcSEcCtD
Tizanidine—Constipation—Pravastatin—atherosclerosis	0.000914	0.00127	CcSEcCtD
Tizanidine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000913	0.00127	CcSEcCtD
Tizanidine—Asthenia—Lovastatin—atherosclerosis	0.000907	0.00126	CcSEcCtD
Tizanidine—Pruritus—Lovastatin—atherosclerosis	0.000894	0.00124	CcSEcCtD
Tizanidine—Asthenia—Ezetimibe—atherosclerosis	0.000889	0.00123	CcSEcCtD
Tizanidine—Gastrointestinal pain—Niacin—atherosclerosis	0.000887	0.00123	CcSEcCtD
Tizanidine—Nausea—Rosuvastatin—atherosclerosis	0.000886	0.00123	CcSEcCtD
Tizanidine—Feeling abnormal—Pravastatin—atherosclerosis	0.00088	0.00122	CcSEcCtD
Tizanidine—Pruritus—Ezetimibe—atherosclerosis	0.000877	0.00122	CcSEcCtD
Tizanidine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000874	0.00121	CcSEcCtD
Tizanidine—Hypersensitivity—Simvastatin—atherosclerosis	0.000871	0.00121	CcSEcCtD
Tizanidine—Diarrhoea—Lovastatin—atherosclerosis	0.000864	0.0012	CcSEcCtD
Tizanidine—Urticaria—Niacin—atherosclerosis	0.000862	0.0012	CcSEcCtD
Tizanidine—Abdominal pain—Niacin—atherosclerosis	0.000858	0.00119	CcSEcCtD
Tizanidine—Body temperature increased—Niacin—atherosclerosis	0.000858	0.00119	CcSEcCtD
Tizanidine—Urticaria—Pravastatin—atherosclerosis	0.000849	0.00118	CcSEcCtD
Tizanidine—Asthenia—Simvastatin—atherosclerosis	0.000848	0.00118	CcSEcCtD
Tizanidine—Diarrhoea—Ezetimibe—atherosclerosis	0.000848	0.00118	CcSEcCtD
Tizanidine—Abdominal pain—Pravastatin—atherosclerosis	0.000845	0.00117	CcSEcCtD
Tizanidine—Body temperature increased—Pravastatin—atherosclerosis	0.000845	0.00117	CcSEcCtD
Tizanidine—Pruritus—Simvastatin—atherosclerosis	0.000836	0.00116	CcSEcCtD
Tizanidine—Dizziness—Lovastatin—atherosclerosis	0.000836	0.00116	CcSEcCtD
Tizanidine—Dizziness—Ezetimibe—atherosclerosis	0.000819	0.00114	CcSEcCtD
Tizanidine—Diarrhoea—Simvastatin—atherosclerosis	0.000809	0.00112	CcSEcCtD
Tizanidine—Vomiting—Lovastatin—atherosclerosis	0.000803	0.00111	CcSEcCtD
Tizanidine—Hypersensitivity—Niacin—atherosclerosis	0.0008	0.00111	CcSEcCtD
Tizanidine—Rash—Lovastatin—atherosclerosis	0.000797	0.0011	CcSEcCtD
Tizanidine—Dermatitis—Lovastatin—atherosclerosis	0.000796	0.0011	CcSEcCtD
Tizanidine—Vomiting—Ezetimibe—atherosclerosis	0.000788	0.00109	CcSEcCtD
Tizanidine—Hypersensitivity—Pravastatin—atherosclerosis	0.000787	0.00109	CcSEcCtD
Tizanidine—Dizziness—Simvastatin—atherosclerosis	0.000782	0.00108	CcSEcCtD
Tizanidine—Rash—Ezetimibe—atherosclerosis	0.000781	0.00108	CcSEcCtD
Tizanidine—Dermatitis—Ezetimibe—atherosclerosis	0.000781	0.00108	CcSEcCtD
Tizanidine—Asthenia—Niacin—atherosclerosis	0.000779	0.00108	CcSEcCtD
Tizanidine—Pruritus—Niacin—atherosclerosis	0.000768	0.00106	CcSEcCtD
Tizanidine—Asthenia—Pravastatin—atherosclerosis	0.000767	0.00106	CcSEcCtD
Tizanidine—Pruritus—Pravastatin—atherosclerosis	0.000756	0.00105	CcSEcCtD
Tizanidine—Vomiting—Simvastatin—atherosclerosis	0.000751	0.00104	CcSEcCtD
Tizanidine—Nausea—Lovastatin—atherosclerosis	0.00075	0.00104	CcSEcCtD
Tizanidine—Rash—Simvastatin—atherosclerosis	0.000745	0.00103	CcSEcCtD
Tizanidine—Dermatitis—Simvastatin—atherosclerosis	0.000744	0.00103	CcSEcCtD
Tizanidine—Diarrhoea—Niacin—atherosclerosis	0.000742	0.00103	CcSEcCtD
Tizanidine—Nausea—Ezetimibe—atherosclerosis	0.000736	0.00102	CcSEcCtD
Tizanidine—Diarrhoea—Pravastatin—atherosclerosis	0.000731	0.00101	CcSEcCtD
Tizanidine—Dizziness—Niacin—atherosclerosis	0.000718	0.000995	CcSEcCtD
Tizanidine—Dizziness—Pravastatin—atherosclerosis	0.000707	0.00098	CcSEcCtD
Tizanidine—Nausea—Simvastatin—atherosclerosis	0.000702	0.000973	CcSEcCtD
Tizanidine—Vomiting—Niacin—atherosclerosis	0.00069	0.000957	CcSEcCtD
Tizanidine—Rash—Niacin—atherosclerosis	0.000684	0.000949	CcSEcCtD
Tizanidine—Dermatitis—Niacin—atherosclerosis	0.000684	0.000948	CcSEcCtD
Tizanidine—Vomiting—Pravastatin—atherosclerosis	0.000679	0.000942	CcSEcCtD
Tizanidine—Rash—Pravastatin—atherosclerosis	0.000674	0.000934	CcSEcCtD
Tizanidine—Dermatitis—Pravastatin—atherosclerosis	0.000673	0.000933	CcSEcCtD
Tizanidine—Nausea—Niacin—atherosclerosis	0.000645	0.000894	CcSEcCtD
Tizanidine—Nausea—Pravastatin—atherosclerosis	0.000635	0.00088	CcSEcCtD
Tizanidine—ADRA2C—Signaling by GPCR—F2—atherosclerosis	6.92e-05	0.000248	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PRKCG—atherosclerosis	6.92e-05	0.000248	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—VEGFA—atherosclerosis	6.91e-05	0.000248	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—VWF—atherosclerosis	6.89e-05	0.000247	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP7A1—atherosclerosis	6.85e-05	0.000246	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOC3—atherosclerosis	6.84e-05	0.000245	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LDLR—atherosclerosis	6.8e-05	0.000244	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TGFB1—atherosclerosis	6.79e-05	0.000243	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KNG1—atherosclerosis	6.77e-05	0.000243	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—HMOX1—atherosclerosis	6.77e-05	0.000243	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AGTR1—atherosclerosis	6.73e-05	0.000241	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AGT—atherosclerosis	6.7e-05	0.00024	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCL3—atherosclerosis	6.64e-05	0.000238	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CG—atherosclerosis	6.63e-05	0.000238	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CCL2—atherosclerosis	6.61e-05	0.000237	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PLG—atherosclerosis	6.56e-05	0.000235	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—MAPK3—atherosclerosis	6.53e-05	0.000234	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	6.53e-05	0.000234	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—APOB—atherosclerosis	6.48e-05	0.000232	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ABCA1—atherosclerosis	6.41e-05	0.00023	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NCF1—atherosclerosis	6.36e-05	0.000228	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TGFB1—atherosclerosis	6.34e-05	0.000227	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP27A1—atherosclerosis	6.33e-05	0.000227	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KNG1—atherosclerosis	6.33e-05	0.000227	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GSTM1—atherosclerosis	6.3e-05	0.000226	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AGTR1—atherosclerosis	6.29e-05	0.000226	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.23e-05	0.000223	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SOCS3—atherosclerosis	6.22e-05	0.000223	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—F2—atherosclerosis	6.19e-05	0.000222	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—LPL—atherosclerosis	6.19e-05	0.000222	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CCL2—atherosclerosis	6.17e-05	0.000221	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PLG—atherosclerosis	6.13e-05	0.00022	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AGT—atherosclerosis	6.09e-05	0.000218	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.08e-05	0.000218	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GPX1—atherosclerosis	6.04e-05	0.000216	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCR2—atherosclerosis	6.01e-05	0.000215	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EDNRA—atherosclerosis	6.01e-05	0.000215	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP3—atherosclerosis	6e-05	0.000215	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	6e-05	0.000215	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	6e-05	0.000215	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOA2—atherosclerosis	6e-05	0.000215	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALOX15—atherosclerosis	6e-05	0.000215	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CYBA—atherosclerosis	5.98e-05	0.000215	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IGF2—atherosclerosis	5.98e-05	0.000214	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CG—atherosclerosis	5.93e-05	0.000213	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ABCG5—atherosclerosis	5.93e-05	0.000213	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	5.92e-05	0.000212	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CD36—atherosclerosis	5.88e-05	0.000211	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PARP1—atherosclerosis	5.86e-05	0.00021	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PLAT—atherosclerosis	5.86e-05	0.00021	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GHRL—atherosclerosis	5.86e-05	0.00021	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SOCS3—atherosclerosis	5.81e-05	0.000208	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOB—atherosclerosis	5.8e-05	0.000208	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CXCL8—atherosclerosis	5.75e-05	0.000206	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LPA—atherosclerosis	5.72e-05	0.000205	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EDN1—atherosclerosis	5.71e-05	0.000205	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCL5—atherosclerosis	5.67e-05	0.000203	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—F2—atherosclerosis	5.62e-05	0.000202	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—VEGFA—atherosclerosis	5.61e-05	0.000201	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP3—atherosclerosis	5.61e-05	0.000201	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IGF2—atherosclerosis	5.58e-05	0.0002	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—MTHFR—atherosclerosis	5.57e-05	0.0002	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—BGN—atherosclerosis	5.54e-05	0.000199	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—LPL—atherosclerosis	5.54e-05	0.000199	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.5e-05	0.000197	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—HMOX1—atherosclerosis	5.5e-05	0.000197	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOA5—atherosclerosis	5.49e-05	0.000197	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPARA—atherosclerosis	5.47e-05	0.000196	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOB—atherosclerosis	5.42e-05	0.000194	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PRKCG—atherosclerosis	5.39e-05	0.000193	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CG—atherosclerosis	5.38e-05	0.000193	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CXCL8—atherosclerosis	5.37e-05	0.000193	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EDN1—atherosclerosis	5.33e-05	0.000191	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.33e-05	0.000191	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—MAPK3—atherosclerosis	5.31e-05	0.00019	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AGT—atherosclerosis	5.29e-05	0.00019	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCL5—atherosclerosis	5.29e-05	0.00019	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	5.28e-05	0.000189	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOB—atherosclerosis	5.26e-05	0.000189	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SPP1—atherosclerosis	5.25e-05	0.000188	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CXCL8—atherosclerosis	5.22e-05	0.000187	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.22e-05	0.000187	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—APOE—atherosclerosis	5.19e-05	0.000186	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LPL—atherosclerosis	5.17e-05	0.000186	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.17e-05	0.000186	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.16e-05	0.000185	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TGFB1—atherosclerosis	5.15e-05	0.000185	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KNG1—atherosclerosis	5.14e-05	0.000184	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CAV1—atherosclerosis	5.14e-05	0.000184	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—APOA1—atherosclerosis	5.13e-05	0.000184	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GSTM1—atherosclerosis	5.12e-05	0.000184	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AGTR1—atherosclerosis	5.11e-05	0.000183	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALOX5—atherosclerosis	5.1e-05	0.000183	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PRKCG—atherosclerosis	5.03e-05	0.00018	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—LPL—atherosclerosis	5.03e-05	0.00018	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CCL2—atherosclerosis	5.01e-05	0.00018	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PLG—atherosclerosis	4.98e-05	0.000179	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GPX1—atherosclerosis	4.9e-05	0.000176	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SPP1—atherosclerosis	4.9e-05	0.000176	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCL8—atherosclerosis	4.88e-05	0.000175	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PDGFB—atherosclerosis	4.85e-05	0.000174	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CD36—atherosclerosis	4.78e-05	0.000171	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AGT—atherosclerosis	4.74e-05	0.00017	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—AKT1—atherosclerosis	4.72e-05	0.000169	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SOCS3—atherosclerosis	4.72e-05	0.000169	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.71e-05	0.000169	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CG—atherosclerosis	4.68e-05	0.000168	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOE—atherosclerosis	4.64e-05	0.000167	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—LEP—atherosclerosis	4.64e-05	0.000167	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CAV1—atherosclerosis	4.6e-05	0.000165	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOA1—atherosclerosis	4.59e-05	0.000165	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NAMPT—atherosclerosis	4.58e-05	0.000164	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	4.55e-05	0.000163	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.55e-05	0.000163	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LIPC—atherosclerosis	4.55e-05	0.000163	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PDGFB—atherosclerosis	4.53e-05	0.000163	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	4.53e-05	0.000163	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—MTHFR—atherosclerosis	4.53e-05	0.000162	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOC3—atherosclerosis	4.52e-05	0.000162	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPARG—atherosclerosis	4.52e-05	0.000162	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LDLR—atherosclerosis	4.49e-05	0.000161	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARA—atherosclerosis	4.44e-05	0.000159	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ESR1—atherosclerosis	4.43e-05	0.000159	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—INS—atherosclerosis	4.43e-05	0.000159	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AGT—atherosclerosis	4.43e-05	0.000159	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—AKT1—atherosclerosis	4.41e-05	0.000158	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOB—atherosclerosis	4.4e-05	0.000158	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CETP—atherosclerosis	4.39e-05	0.000157	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—F2—atherosclerosis	4.38e-05	0.000157	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	4.36e-05	0.000156	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOE—atherosclerosis	4.34e-05	0.000156	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LEP—atherosclerosis	4.34e-05	0.000156	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	4.33e-05	0.000155	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AGT—atherosclerosis	4.3e-05	0.000154	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	4.3e-05	0.000154	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CAV1—atherosclerosis	4.3e-05	0.000154	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOA1—atherosclerosis	4.29e-05	0.000154	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOE—atherosclerosis	4.21e-05	0.000151	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LPL—atherosclerosis	4.2e-05	0.000151	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SCARB1—atherosclerosis	4.2e-05	0.000151	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CG—atherosclerosis	4.19e-05	0.00015	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CAV1—atherosclerosis	4.17e-05	0.00015	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOA1—atherosclerosis	4.17e-05	0.000149	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ESR1—atherosclerosis	4.14e-05	0.000148	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—F2—atherosclerosis	4.09e-05	0.000147	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.09e-05	0.000147	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	4.09e-05	0.000147	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALB—atherosclerosis	4.06e-05	0.000146	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	4.01e-05	0.000144	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	3.98e-05	0.000143	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HMGCR—atherosclerosis	3.97e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—INS—atherosclerosis	3.97e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	3.96e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CG—atherosclerosis	3.91e-05	0.00014	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	3.9e-05	0.00014	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—NOS3—atherosclerosis	3.89e-05	0.000139	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	3.84e-05	0.000138	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CG—atherosclerosis	3.8e-05	0.000136	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—MAPK3—atherosclerosis	3.75e-05	0.000134	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—INS—atherosclerosis	3.71e-05	0.000133	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	3.68e-05	0.000132	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARG—atherosclerosis	3.67e-05	0.000132	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCL2—atherosclerosis	3.65e-05	0.000131	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	3.64e-05	0.000131	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—INS—atherosclerosis	3.6e-05	0.000129	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AGT—atherosclerosis	3.6e-05	0.000129	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IGF1—atherosclerosis	3.58e-05	0.000129	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—AKT1—atherosclerosis	3.58e-05	0.000128	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.58e-05	0.000128	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTGS2—atherosclerosis	3.55e-05	0.000127	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ABCA1—atherosclerosis	3.54e-05	0.000127	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LEP—atherosclerosis	3.52e-05	0.000126	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOE—atherosclerosis	3.52e-05	0.000126	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	3.49e-05	0.000125	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	3.48e-05	0.000125	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	3.48e-05	0.000125	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SERPINE1—atherosclerosis	3.4e-05	0.000122	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	3.36e-05	0.000121	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—F2—atherosclerosis	3.32e-05	0.000119	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALB—atherosclerosis	3.3e-05	0.000118	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	3.25e-05	0.000117	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	3.18e-05	0.000114	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—NOS3—atherosclerosis	3.16e-05	0.000113	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	3.09e-05	0.000111	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	3.05e-05	0.000109	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.03e-05	0.000109	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—INS—atherosclerosis	3.01e-05	0.000108	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	2.98e-05	0.000107	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	2.96e-05	0.000106	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	2.93e-05	0.000105	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	2.91e-05	0.000104	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOB—atherosclerosis	2.91e-05	0.000104	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTGS2—atherosclerosis	2.89e-05	0.000104	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	2.88e-05	0.000103	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTM1—atherosclerosis	2.83e-05	0.000101	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	2.79e-05	0.0001	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	2.78e-05	9.98e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LPL—atherosclerosis	2.77e-05	9.95e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	2.76e-05	9.91e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	2.76e-05	9.9e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	2.74e-05	9.83e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	2.71e-05	9.73e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GPX1—atherosclerosis	2.71e-05	9.71e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	2.71e-05	9.71e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	2.64e-05	9.46e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CD36—atherosclerosis	2.64e-05	9.45e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	2.61e-05	9.35e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	2.58e-05	9.25e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	2.54e-05	9.09e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	2.53e-05	9.07e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	2.51e-05	8.99e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.5e-05	8.96e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	2.48e-05	8.9e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARA—atherosclerosis	2.45e-05	8.79e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AGT—atherosclerosis	2.37e-05	8.51e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	2.37e-05	8.5e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	2.34e-05	8.4e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	2.34e-05	8.39e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOE—atherosclerosis	2.33e-05	8.34e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	2.32e-05	8.31e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CAV1—atherosclerosis	2.3e-05	8.26e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	2.3e-05	8.25e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOA1—atherosclerosis	2.3e-05	8.24e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	2.26e-05	8.11e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	2.23e-05	7.98e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	2.21e-05	7.94e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	2.15e-05	7.7e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	2.12e-05	7.59e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.1e-05	7.53e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	2.1e-05	7.51e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	2.06e-05	7.38e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	2.05e-05	7.36e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARG—atherosclerosis	2.03e-05	7.26e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—INS—atherosclerosis	1.99e-05	7.12e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	1.9e-05	6.82e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	1.88e-05	6.75e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALB—atherosclerosis	1.82e-05	6.53e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	1.8e-05	6.45e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AKT1—atherosclerosis	1.79e-05	6.41e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	1.75e-05	6.26e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NOS3—atherosclerosis	1.74e-05	6.25e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6—atherosclerosis	1.73e-05	6.22e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6—atherosclerosis	1.62e-05	5.81e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	1.6e-05	5.73e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.59e-05	5.71e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	1.49e-05	5.36e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AKT1—atherosclerosis	1.45e-05	5.2e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	1.32e-05	4.72e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	1.21e-05	4.35e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKT1—atherosclerosis	8.01e-06	2.87e-05	CbGpPWpGaD
